AAAAAA
Results:
1-19
|
Results: 19
Authors:
BALTALI E
FIRAT D
ONCEL N
ONAT DA
ATAHAN IL
BUYUKUNAL E
CELIK I
AKTAN G
Citation: E. Baltali et al., NEOADJUVANT CHEMOTHERAPY IN LOCALLY-ADVANCED BREAST-CANCER - A PRELIMINARY-REPORT, European journal of cancer, 34, 1998, pp. 80-80
Authors:
GULER N
BALTALI E
ALTINDAG K
OZISIK Y
TEKUZMAN G
FIRAT D
Citation: N. Guler et al., PACLITAXEL IN THE SALVAGE TREATMENT OF METASTATIC BREAST-CARCINOMA, Annals of oncology, 9, 1998, pp. 144-144
Authors:
YALCIN S
TEKUZMAN G
BALTALI E
OZISIK Y
BARISTA I
ZENGIN N
Citation: S. Yalcin et al., 5-HT3 RECEPTOR ANTAGONISTS IN PROPHYLAXIS OF ACUTE AND DELAYED EMESISINDUCED BY MODERATELY EMETOGENIC SINGLE DAY CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 718-718
Authors:
YALCIN S
KARS A
OZISIK Y
TEKUZMAN G
OZYILKAN O
CELIK I
BARISTA I
GULLU I
GULER N
BALTALI E
FIRAT D
Citation: S. Yalcin et al., VB-CHEP CHEMOTHERAPY REGIMEN FOR AGGRESSIVE NON-HODGKINS-LYMPHOMAS, European journal of haematology, 61(4), 1998, pp. 261-265
Authors:
KOC Y
AKPEK G
KANSU E
KARS A
TEKUZMAN G
BALTALI E
GULER N
BARISTA I
GULLU I
OZISIK Y
FIRAT D
Citation: Y. Koc et al., BOLUS AND CONTINUOUS-INFUSION MITOXANTRONE IN NEWLY-DIAGNOSED ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF 2 CONSECUTIVE PHASE-II CLINICAL-STUDIES, Cancer investigation, 16(6), 1998, pp. 355-365
Authors:
OZYILKAN O
BALTALI E
OZDEMIR O
TEKUZMAN G
KIRAZLI S
FIRAT D
Citation: O. Ozyilkan et al., HEMOSTATIC CHANGES - PLASMA-LEVELS OF ALPHA2-ANTIPLASMIN-PLASMIN COMPLEX AND THROMBIN-ANTITHROMBIN-III COMPLEX IN FEMALE BREAST-CANCER, Tumori, 84(3), 1998, pp. 364-367
Authors:
OZYILKAN O
BALTALI E
TEKUZMAN G
FIRAT D
Citation: O. Ozyilkan et al., THE IMPACT OF DIAGNOSIS AND TREATMENT ON THE QUALITY-OF-LIFE IN BREAST-CANCER PATIENTS, Neoplasma, 45(1), 1998, pp. 50-52
Authors:
USTUNDAG Y
BOYACIOGLU S
HAZNEDAROGLU IC
BALTALI E
Citation: Y. Ustundag et al., ACUTE TUMOR LYSIS SYNDROME-ASSOCIATED WITH PACLITAXEL, The Annals of pharmacotherapy, 31(12), 1997, pp. 1548-1549
Authors:
KIRAZ S
BALTALI E
GULER N
BARISTA I
BENEKLI M
CELIK I
GULLU IH
KARS A
TEKUZMAN G
FIRAT D
Citation: S. Kiraz et al., IFOSFAMIDE AND ETOPOSIDE IN PREVIOUSLY TREATED PATIENTS WITH ADVANCEDBREAST-CANCER, Tumori, 83(2), 1997, pp. 604-607
Authors:
KOSTAKOGLU L
ELAHI N
KIRATLI P
RUACAN S
SAYEK I
BALTALI E
SUNGUR A
HAYRAN M
BEKDIK CF
Citation: L. Kostakoglu et al., CLINICAL VALIDATION OF THE INFLUENCE OF P-GLYCOPROTEIN ON TECHNETIUM-99M-SESTAMIBI UPTAKE IN MALIGNANT-TUMORS, The Journal of nuclear medicine, 38(7), 1997, pp. 1003-1008
Authors:
KIRAZ S
BALTALI E
GULER N
BARISTA I
BENEKLI M
CELIK I
GULLU IH
KARS A
TEKUZMAN G
FIRAT D
Citation: S. Kiraz et al., IFOSFAMIDE, MESNA AND EPIRUBICIN AS 2ND-LINE CHEMOTHERAPY IN ADVANCEDBREAST-CANCER, Journal of chemotherapy, 8(4), 1996, pp. 310-314
Authors:
GULLU I
YALCIN S
TEKUZMAN G
BARISTA I
ALKIS N
CELIK I
ZENGIN N
GULER N
KARS A
BALTALI E
KANSU E
FIRAT D
Citation: I. Gullu et al., HIGH-DOSE IFOSFAMIDE BY INFUSION WITH MESNA IN ADVANCED REFRACTORY SARCOMAS, Cancer investigation, 14(3), 1996, pp. 239-242
Authors:
GULLU IH
CELIK I
TEKUZMAN G
ALTUNBAS M
GULER N
BARISTA I
ALKIS N
YALCIN S
KARS A
BALTALI E
KANSU E
FIRAT D
Citation: Ih. Gullu et al., PROCARBAZINE, CCNU, VINCRISTINE COMBINATION IN THE TREATMENT OF BRAIN-TUMORS, Tumori, 82(3), 1996, pp. 228-231
Authors:
BARISTA I
BALTALI E
GULLU IH
GULER N
CELIK I
SARACBASI O
TEKUZMAN G
KARS A
OZISIK Y
RUACAN S
ATAHAN IL
FIRAT D
Citation: I. Barista et al., FACTORS INFLUENCING THE DISTRIBUTION OF METASTASES AND SURVIVAL IN METASTATIC BREAST-CARCINOMA, American journal of clinical oncology, 19(6), 1996, pp. 569-573
Authors:
KARS A
CELIK I
KANSU E
OZISIK Y
GULER N
BARISTA I
GULLU IH
YALCIN S
ALTUNDAG K
ZENGIN N
TEKUZMAN G
BALTALI E
FIRAT D
Citation: A. Kars et al., VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE CHEMOTHERAPY WITH OR WITHOUT INTERFERON-ALPHA-2B MAINTENANCE IN MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 3609-3609
Authors:
GULER N
BALTALI E
KARS A
OZISIK Y
ENUNLU T
TEKUZMAN G
OZYILKAN O
ONAT D
GULLU I
BARISTA I
FIRAT D
Citation: N. Guler et al., CMF OR CMF-IIIA BREAST-CARCINOMA(RT AS ADJUVANT THERAPY IN PATIENTS WITH STAGE I), European journal of cancer, 31A, 1995, pp. 70-70
Authors:
YALCIN S
GULER N
KANSU E
ERTENLI I
GULLU I
KARS A
AKPEK G
BARISTA I
TEKUZMAN G
BALTALI E
Citation: S. Yalcin et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) ADMINISTRATION FOR CHEMOTHERAPY-INDUCED NEUTROPENIA, European journal of cancer, 31A, 1995, pp. 591-591
Authors:
BARISTA I
TEKUZMAN G
GULLU I
BALTALI E
KARS A
OZISIK Y
GULER N
CELIK I
ATAHAN IL
FIRAT D
Citation: I. Barista et al., NON-HODGKINS-LYMPHOMAS OF THE TONSIL - A RETROSPECTIVE ANALYSIS OF 28PATIENTS WITH PRIMARY TONSILLARY LYMPHOMA, Tumori, 81(4), 1995, pp. 234-237
Authors:
BARISTA I
TEKUZMAN G
FIRAT D
BALTALI E
KANSU E
KARS A
OZISIK Y
RUACAN S
UZUNALIMOGLU B
KARAAGAOGLU E
Citation: I. Barista et al., NON-HODGKINS-LYMPHOMAS IN TURKEY - 18 YEARS EXPERIENCE AT THE HACETTEPE-UNIVERSITY, Japanese journal of cancer research, 85(12), 1994, pp. 1200-1207
Risultati:
1-19
|